Muutke küpsiste eelistusi

E-raamat: Nanotechnology for Infectious Diseases

Edited by , Edited by
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 13-Apr-2022
  • Kirjastus: Springer Verlag, Singapore
  • Keel: eng
  • ISBN-13: 9789811691904
  • Formaat - EPUB+DRM
  • Hind: 271,08 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 13-Apr-2022
  • Kirjastus: Springer Verlag, Singapore
  • Keel: eng
  • ISBN-13: 9789811691904

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book aims to cover the applications of nanotechnology against human infectious diseases. The chapters of the book discuss the role of nanotechnology in the efficient diagnosis and treatment of these diseases. It explicitly provides an overview of nanodiagnostics for infectious diseases from nanoparticles-based, nanodevice-based, and point-of-care platforms. The book also covers the state-of-the-art review of recent progress in biomimetic and bioengineered nanotherapies to treat infectious diseases. It also presents a nano carrier-based CRISPR/Cas9 delivery system for gene editing and its applications for developing interventional approaches against communicable diseases. Further, it reviews the recent developments in nanotechnology to engineer nanoparticles with desired physicochemical properties as a line of defense against multi-drug resistance micro-organisms. Cutting across the disciplines, this book serves as a guide for researchers in biotechnology, parasitology, and nanotechnology.


?
Dr. Saif Hameed is currently working as an Associate Professor at Amity Institute of Biotechnology, Amity University Haryana (AUH). He did his bachelors from the University of Delhi and Masters from Jamia Hamdard. He completed his doctoral studies in Life Sciences from the Jawaharlal Nehru University. He was a Visiting Scholar in Institut für Mikrobiologie, Heinrich-Heine-Universität, Düsseldorf, Germany. He received Young Scientist award under the Fast Track Scheme from the Science and Engineering Research Board, Department of Science and Technology, New Delhi. Dr. Hameed is a life member of the International Society of Infectious Diseases (ISID), Association for Microbiologist (AMI), India, and Society of Biological Chemists (SBC), India. Dr. Hameed is actively engaged in research in the field of infectious diseases, particularly on multidrug resistance (MDR) in pathogenic fungi. He has published more than 60 research articles in peer-reviewed international journals and edited 5 books, and contributed 25 book chapters.

Dr. Suriya Rehman is currently working as an Assistant professor in the Department of Epidemic Diseases Research, Institute for Research and Medical Consultation, Imam Abdulrahman Bin University, Dammam, Saudi Arabia. She has obtained her Ph.D. in Microbial Toxicology from Jamia Hamdard (Hamdard University), New Delhi and Council for Scientific Industrial Research, IIIM Jammu/Srinagar, in 2010. She has extensive research experience in the field of infectious diseases, multidrug resistance (MDR), nanotechnology, drug development, and cancer therapeutics. She has published more than 70 peer-reviewed research articles in the international journals of high repute and has edited one book. She is a member of the editorial board of several international journals.